These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 9186699)

  • 1. IgG-fibronectin complexes mimic antibodies to denatured collagen type II.
    Mannik M; Kapil S; Merrill CE
    Ann N Y Acad Sci; 1997 Apr; 815():467-8. PubMed ID: 9186699
    [No Abstract]   [Full Text] [Related]  

  • 2. In patients with rheumatoid arthritis IgG binding to denatured collagen type II is in part mediated by IgG-fibronectin complexes.
    Mannik M; Kapil S; Merrill CE
    J Immunol; 1997 Feb; 158(3):1446-52. PubMed ID: 9013990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Binding of collagen type II to rheumatoid synovial cells.
    Klareskog L; Rubin K; Holmdahl R
    Scand J Immunol; 1986 Dec; 24(6):705-14. PubMed ID: 3798024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IgG subclass distribution of antinative type II collagen and antidenatured type II collagen antibodies in patients with rheumatoid arthritis.
    Collins I; Morgan K; Clague RB; Brenchley PE; Holt PJ
    J Rheumatol; 1988; 15(5):770-4. PubMed ID: 3050082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prevalence of serum IgG antibodies to type II collagen in American patients with rheumatoid arthritis.
    Clague RB; Morgan K; Reynolds I; Williams HJ
    Br J Rheumatol; 1994 Apr; 33(4):336-8. PubMed ID: 8156304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-collagen antibodies in sera from rheumatoid arthritis patients.
    Beard HK; Ryvar R; Skingle J; Greenbury CL
    J Clin Pathol; 1980 Nov; 33(11):1077-81. PubMed ID: 6255015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Affinity of myeloma IgG proteins for fibronectin.
    Hautanen A; Keski-Oja J
    Clin Exp Immunol; 1983 Jul; 53(1):233-8. PubMed ID: 6347476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pepsinogen--an immunoglobulin binding artefact in 'collagen' preparations.
    Kirk AP; O'Hara BP; Mageed RA; McMahon MS; McCarthy D; Menashi S; Archer JR; Currey HL
    Clin Exp Immunol; 1986 Sep; 65(3):671-8. PubMed ID: 3780048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High levels of anti-type II collagen IgG in west African patients with rheumatoid arthritis.
    Adebajo AO; Williams RO; Williams DG; Hazleman BL; Maini RN
    J Rheumatol; 1994 Dec; 21(12):2206-8. PubMed ID: 7699620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibodies to native and denatured type II collagen in children with rheumatic diseases.
    Rosenberg AM; Hunt DW; Petty RE
    J Rheumatol; 1984 Aug; 11(4):425-31. PubMed ID: 6332907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence of serum antibodies to native type I and type II collagens in patients with inflammatory arthritis.
    Clague RB; Shaw MJ; Holt PJ
    Ann Rheum Dis; 1980 Jun; 39(3):201-6. PubMed ID: 7416811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Demonstration of antibodies to collagen and of collagen-anticollagen immune complexes in rheumatoid arthritis synovial fluids.
    Menzel J; Steffen C; Kolarz G; Eberal G; Frank O; Thumb N
    Ann Rheum Dis; 1975 Oct; 35(5):446-50. PubMed ID: 185972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential pathogenicity of deglycosylated IgG cross reactive with streptokinase and fibronectin in the serum of patients with rheumatoid arthritis.
    Cuchacovich M; Gatica H; Grigg DM; Pizzo SV; Gonzalez-Gronow M
    J Rheumatol; 1996 Jan; 23(1):44-51. PubMed ID: 8838507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence and correlation between serum IgG and IgM antibodies to native type II collagen in patients with chronic inflammatory arthritis.
    Clague RB; Shaw MJ; Holt PJ
    Ann Rheum Dis; 1981 Feb; 40(1):6-10. PubMed ID: 7469526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence of antibodies to native and denatured cartilage collagens (types II, IX, and XI) and to type I collagen in rheumatoid arthritis.
    Morgan K; Clague RB; Collins I; Ayad S; Phinn SD; Holt PJ
    Ann Rheum Dis; 1987 Dec; 46(12):902-7. PubMed ID: 3426299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of binding between cryoimmunoglobulins, immunoglobulins and fibronectin: implications for immune complex vasculitis.
    Brandau DT; O'Donnell R; Kimmel-Truitt VL
    Clin Exp Immunol; 1991 Jan; 83(1):58-63. PubMed ID: 1824833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum and synovial fluid antibodies to collagen in rheumatic diseases: a review.
    Verbruggen LA; Geerts A; Wisse E; Lapiere C
    Clin Rheumatol; 1986 Dec; 5(4):440-4. PubMed ID: 3816091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibodies to the collagen-like region of C1q and type II collagen are independent non-cross-reactive populations in systemic lupus erythematosus and rheumatoid arthritis.
    Cook AD; Rowley MJ; Wines BD; Mackay IR
    J Autoimmun; 1994 Jun; 7(3):369-78. PubMed ID: 7522456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Passive transfer of arthritis to mice by injection of human anti-type II collagen antibody.
    Wooley PH; Luthra HS; Singh SK; Huse AR; Stuart JM; David CS
    Mayo Clin Proc; 1984 Nov; 59(11):737-43. PubMed ID: 6492869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Interaction between fibronectin and aggregated IgG].
    Menzel EJ; Borth W; Kaik B
    Wien Klin Wochenschr; 1983 Dec; 95(24):880-4. PubMed ID: 6608184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.